Top Markets
#1 Akedo Akedo +195.32%
#2 ONFA ONFA +54.15%
#3 Talus Network Talus Network +27.78%
#4 Osaka Protocol Osaka Protocol +21.37%
#5 0G 0G +21.23%
#6 Metaplex Metaplex +20.26%
#7 Wrapped Krown Wrapped Krown +19.97%
#8 EVAA Protocol EVAA Protocol +18.16%
#9 eCash eCash +15.89%
#10 Unibase Unibase +15.04%
Coin of the day
Akedo Akedo
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Pfizer Inc. Pfizer Inc.

Pfizer Inc.

PFE
Clasificación en acciones #146
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells... Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Precio por acción
$24.25
Capitalización bursátil
$138.21B
Cambio (1 día)
-0.94%
Cambio (1 año)
194.85%
País
US
Comercio Pfizer Inc. (PFE)

Categoría

Healthcare
Ratio P/B de Pfizer Inc. (PFE)
Ratio P/B al 2026 TTM: 0
Según los informes financieros más recientes y el precio de las acciones de Pfizer Inc., el ratio P/B actual (TTM) es 0. Al final de 2026, el ratio P/B era 0.
Historial del ratio P/B de Pfizer Inc. desde 2026 hasta 2026
Ratio P/B al final de cada año
Año Ratio P/B Cambiar
Not enough data for the provided dates.
Ratio P/B de empresas similares o competidoras
Empresa Ratio P/B Diferencia del ratio P/B País
Eli Lilly Eli Lilly
Eli Lilly
LLY.US
 33.0453 -
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
 7.6457 -
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
 15.7899 -
US
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
 6.509 -
US
Novartis AG Novartis AG
Novartis AG
NVS.US
 7.4763 -
CH